The impact of COVID-19 pandemic on the diagnosis and management of inborn errors of metabolism: A global perspective
Authors:
- Mohamed A. ElmonemMohamed A. Elmonem
- Amaya Belanger-QuintanaABAmaya Belanger-Quintana
- Andrea BordugoABAndrea Bordugo
- Ritma BoruahRBRitma Boruah
- Elisenda Cortès-SaladelafontECElisenda Cortès-Saladelafont
- Mounika EndrakantiMEMounika Endrakanti
- Pilar GiraldoPGPilar Giraldo
- Sarah Catharina GrünertSarah Catharina Grünert
- Neerja GuptaNGNeerja Gupta
- Madhulika KabraMKMadhulika Kabra
- Ina KnerrIKIna Knerr
- Johannes KrämerJKJohannes Krämer
- 1 November 2020
- journal article
- editorial
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 131 (3) , 285-288
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experienceMolecular Genetics and Metabolism, 2020
- Fabry disease during the COVID-19 pandemic. Why and how treatment should be continuedMolecular Genetics and Metabolism, 2020
- Gaucher disease and SARS-CoV-2 infection: Emerging management challengesMolecular Genetics and Metabolism, 2020
- Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experienceMolecular Genetics and Metabolism, 2020
- Chinese expert brief consensus on newborn screening of inherited metabolic disorders during the novel coronavirus infection epidemicAnnals of Translational Medicine, 2020
- Chemical individuality in T cells: A Garrodian view of immunometabolismImmunological Reviews, 2020
- Inborn Errors of Metabolism in the Era of Untargeted Metabolomics and LipidomicsMetabolites, 2019
- A proposed nosology of inborn errors of metabolismGenetics in Medicine, 2018
- Inborn errors of metabolism underlying primary immunodeficienciesJournal of Clinical Immunology, 2014